Filippo Rosselli

Filippo Rosselli

Auto-generated profile, based on publicly available information

Filippo Rosselli

Université Paris Sud, UMR8200, « Equipe Labellisée Ligue Contre le Cancer », Institut de Cancérologie Gustave-Roussy, Villejuif, France

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
PPPietro Pichierri
Pietro Pichierri
FRFilippo Rosselli
Filippo Rosselli
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 July 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
PPPietro Pichierri
Pietro Pichierri
AFAnnapaola Franchitto
Annapaola Franchitto
FRFilippo Rosselli
Filippo Rosselli
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

9 March 2011 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JGJean-Hugues Guervilly
Jean-Hugues Guervilly
EREmilie Renaud
Emilie Renaud
MTMinoru Takata
Minoru Takata
FRFilippo Rosselli
Filippo Rosselli
The maintenance of genetic stability depends on the fine-tuned initiation and termination of pathways involved in cell cycle checkpoints and DNA repair. Here, we describe a new pathway that regulates checkpoint kinase 1 (CHK1) activity, a key element controlling both checkpoints and DNA repair. We show that the ubiquitin-specific peptidase 1 (USP1) deubiquitinase participates in the maintenance of both total and phosphorylated levels of CHK1 in response to genotoxic stress. We establish that USP1 depletion stimulates the damage-specific DNA-binding protein 1-dependent degradation of phosphorylated CHK1 in both a monoubiquitinylated Fanconi anaemia, complementation group D2 (FANCD2)-dependent and -independent manner. Our data support the existence of a circuit in which CHK1 activates checkpoints, DNA repair and proliferating cell nuclear antigen and FANCD2 monoubiquitinylation. The latter two events, in turn, switch off activated CHK1 by negative feedback inhibition, which contributes to the downregulation of the DNA damage response. This pathway, which is compromised in the cancer-prone disease Fanconi anaemia (FA), likely contributes to the hypersensitivity of cells from FA patients to DNA damage and to the clinical phenotype of the syndrome; it may also represent a pharmacological target to improve patient care and develop new cancer therapies.

21 August 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SCSophie Couvé-Privat
Sophie Couvé-Privat
GMGaëtane Macé
Gaëtane Macé
FRFilippo Rosselli
Filippo Rosselli
MSMurat Saparbaev
Murat Saparbaev
Interstrand cross-link (ICL) is a covalent modification of both strands of DNA, which prevents DNA strand separation during transcription and replication. Upon photoactivation 8-methoxypsoralen (8-MOP+UVA) alkylates both strands of DNA duplex at the 5,6-double bond of thymidines, generating monoadducts (MAs) and ICLs. It was thought that bulky DNA lesions such as MAs are eliminated only in the nucleotide excision repair pathway. Instead, non-bulky DNA lesions are substrates for DNA glycosylases and AP endonucleases which initiate the base excision repair (BER) pathway. Here we examined whether BER might be involved in the removal of psoralen–DNA photoadducts. The results show that in human cells DNA glycosylase NEIL1 excises the MAs in duplex DNA, subsequently the apurinic/apyrimidinic endonuclease 1, APE1, removes the 3′-phosphate residue at single-strand break generated by NEIL1. The apparent kinetic parameters suggest that NEIL1 excises MAs with high efficiency. Consistent with these results HeLa cells lacking APE1 and/or NEIL1 become hypersensitive to 8-MOP+UVA exposure. Furthermore, we demonstrate that bacterial homologues of NEIL1, the Fpg and Nei proteins, also excise MAs. New substrate specificity of the Fpg/Nei protein family provides an alternative repair pathway for ICLs and bulky DNA damage.

15 September 2009 in Cell Cycle
Verified
Journal Article
Closed access
PDF file
VNValeria Naim
Valeria Naim
FRFilippo Rosselli
Filippo Rosselli
Fanconi anemia (FA) is a chromosome instability syndrome characterized by progressive bone marrow failure and cancer proneness. The proteins mutated in FA constitute the so-called FANC/BRCA pathway, involved in DNA replication and damage response. However, it is not completely understood how the FANC proteins perform their functions and maintain chromosome stability. Two recently published works reported that FANCD2 localizes to discrete sites on mitotic chromosomes, as consequence of replication fork stalling. The FANC pathway proved to be required to promote BLM-mediated anaphase resolution of chromosome entanglements induced by replication stress. It has also been shown that chromosome entanglement derives from DNA intertwining at fragile sites and that FANCD2 specifically targets these sites. Collectively, our data highlight a new role for the FANC proteins in the prevention of chromosome instability and aneuploidy. These findings open new directions in understanding the mechanisms of chromosome fragility and the role of FANC proteins in preserving genome stability.

20 November 2007 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JGJean-Hugues Guervilly
Jean-Hugues Guervilly
GMGaëtane Macé-Aimé
Gaëtane Macé-Aimé
FRFilippo Rosselli
Filippo Rosselli
Fanconi anemia (FA) is a cancer-prone hereditary disease resulting from mutations in one of the 13 genes defining the FANC/BRCA pathway. This pathway is involved in the cellular resistance to DNA-cross-linking agents. How the FANC/BRCA pathway is activated and why its deficiency leads to the accumulation of FA cells with a 4N DNA content are still poorly answered questions. We investigated the involvement of ATR pathway members in these processes. We show here that RAD9 and RAD17 are required for DNA interstrand cross-link (ICL) resistance and for the optimal activation of FANCD2. Moreover, we demonstrate that CHK1 and its interacting partner CLASPIN that act downstream in the ATR pathway are required for both FANCD2 monoubiquitination and assembling in subnuclear foci in response to DNA damage. Paradoxically, in the absence of any genotoxic stress, CHK1 or CLASPIN depletion results in an increased basal level of FANCD2 monoubiquitination and focalization. We also demonstrate that the ICL-induced accumulation of FA cells in late S/G2 phase is dependent on ATR and CHK1. In agreement with this, CHK1 phosphorylation is enhanced in FA cells, and chemical inhibition of the ATR/CHK1 axis in FA lymphoblasts decreases their sensitivity to mitomycin C. In conclusion, this work describes a complex crosstalk between CHK1 and the FANC/BRCA pathway: CHK1 activates this pathway through FANCD2 monoubiquitination, whereas FA deficiency leads to a CHK1-dependent G2 accumulation, raising the possibility that the FANC/BRCA pathway downregulates CHK1 activation.